David P. Speert mainly focuses on Microbiology, Burkholderia cepacia complex, Pseudomonas aeruginosa, Genomovar and Burkholderia. His Microbiology research incorporates themes from Bacterial genetics, Cystic fibrosis, Virulence and Bacteria. David P. Speert focuses mostly in the field of Burkholderia cepacia complex, narrowing it down to topics relating to Multilocus sequence typing and, in certain cases, Sequence analysis.
His research in Pseudomonas aeruginosa intersects with topics in Efflux, Antibiotic resistance and Immunology, Chronic granulomatous disease. His Immunology research includes elements of Staphylococcus aureus and Pseudomonadaceae. As a part of the same scientific family, David P. Speert mostly works in the field of Genomovar, focusing on Burkholderia multivorans and, on occasion, Burkholderia vietnamiensis, Burkholderia stabilis and Typing.
His primary scientific interests are in Microbiology, Cystic fibrosis, Immunology, Pseudomonas aeruginosa and Burkholderia cepacia complex. His research integrates issues of Burkholderia multivorans, Virulence and Burkholderia, Bacteria in his study of Microbiology. David P. Speert interconnects Phenotype, Chronic infection, Antibiotic resistance and Virology in the investigation of issues within Virulence.
His work deals with themes such as Dextran, Sputum, Lung and Biofilm, which intersect with Cystic fibrosis. In his research on the topic of Pseudomonas aeruginosa, Antimicrobial is strongly related with Antibiotics. His Burkholderia cepacia complex research is multidisciplinary, incorporating elements of Burkholderia cenocepacia and Multilocus sequence typing.
His primary areas of investigation include Microbiology, Immunology, Burkholderia cepacia complex, Cystic fibrosis and Pseudomonas aeruginosa. His Microbiology study integrates concerns from other disciplines, such as Burkholderia multivorans, Burkholderia, Virulence and Biofilm. His studies deal with areas such as Tobramycin and Polymyxin as well as Burkholderia cepacia complex.
His biological study spans a wide range of topics, including Chronic infection, Lung and Gene. His Pseudomonas aeruginosa study incorporates themes from Internal medicine and Antibiotics. David P. Speert combines subjects such as Respiratory disease and Clinical significance with his study of Bacteria.
David P. Speert focuses on Microbiology, Cystic fibrosis, Burkholderia cepacia complex, Immunology and Bacteria. His study in Microbiology is interdisciplinary in nature, drawing from both Recombinant DNA, Escherichia coli, Molecular biology, Burkholderia multivorans and Chronic infection. David P. Speert has researched Cystic fibrosis in several fields, including Pseudomonas aeruginosa and Lung.
His Pseudomonas aeruginosa study combines topics in areas such as Infectious disease, Antibiotics and C-reactive protein. His Burkholderia cepacia complex research is multidisciplinary, incorporating perspectives in Epidemiology, Infection control, Mutant, Colistin and Polymyxin B. His research links Virulence with Bacteria.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression.
Franz G. Bauernfeind;Gabor Horvath;Andrea Stutz;Emad S. Alnemri.
Journal of Immunology (2009)
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.
Eric E. Smith;Danielle G. Buckley;Zaining Wu;Channakhone Saenphimmachak.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment.
Robert E.W. Hancock;David P. Speert.
Drug Resistance Updates (2000)
The Cationic Antimicrobial Peptide LL-37 Modulates Dendritic Cell Differentiation and Dendritic Cell-Induced T Cell Polarization
Donald J. Davidson;Andrew J. Currie;Gregor S. D. Reid;Dawn M. E. Bowdish.
Journal of Immunology (2004)
Selective predisposition to bacterial infections in IRAK-4–deficient children: IRAK-4–dependent TLRs are otherwise redundant in protective immunity
Cheng Lung Ku;Horst Von Bernuth;Horst Von Bernuth;Capucine Picard;Shen Ying Zhang.
Journal of Experimental Medicine (2007)
Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency
Capucine Picard;Capucine Picard;Horst Von Bernuth;Horst Von Bernuth;Horst Von Bernuth;Pegah Ghandil;Pegah Ghandil;Pegah Ghandil;Maya Chrabieh;Maya Chrabieh.
Diagnostically and Experimentally Useful Panel of Strains from the Burkholderia cepacia Complex
Eshwar Mahenthiralingam;Tom Coenye;Jacqueline W. Chung;David P. Speert.
Journal of Clinical Microbiology (2000)
Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
Elke Vanlaere;Adam Baldwin;Dirk Gevers;Deborah Henry.
International Journal of Systematic and Evolutionary Microbiology (2009)
Human TLR-7-, -8-, and -9-Mediated Induction of IFN-α/β and -λ Is IRAK-4 Dependent and Redundant for Protective Immunity to Viruses
Kun Yang;Kun Yang;Anne Puel;Shenying Zhang;Shenying Zhang;Céline Eidenschenk.
Multidrug Efflux Systems Play an Important Role in the Invasiveness of Pseudomonas aeruginosa
Yoichi Hirakata;Ramakrishnan Srikumar;Keith Poole;Naomasa Gotoh.
Journal of Experimental Medicine (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: